iMed is South Africa’s first privately owned forensic toxicology laboratory. We feature state-of-the-art automation of results, and offer the easiest and fastest shipping and handling of samples.


PCRForensic Toxicology

What We Do?

iMed Laboratories provides fast, cost-effective results using testing protocols that are validated for the intended use in compliance with international standards. We produce accurate and legally defensible results. South Africa is a hotbed of exotic recreational drugs that many traditional drug tests aren’t designed to screen. iMed has focused its research and development efforts on tests that detect the substances being consumed by our local population because screening is pointless if the typical South African drug abuse profile isn’t considered.

How does it work?

The validity of test results depends on the quality and integrity of the samples received, and the preservation of an unbroken chain of custody. As part of our services, we provide in-depth training to our corporate clients to ensure that the specimen collection process supports legally defensible drug testing. This also protects the specimen donors. iMed Laboratories has processes and procedures in place to be followed for receipt, inspection and registration of samples. These measures protect the quality and integrity of the samples, as well as the chain of custody.

We use a comprehensive Laboratory Information Management System (LIMS) that meets HIPAA and FDA guidelines, including 21 requirements from Part 11 of the Code of Federal Regulations (CFR). We adhere to these standards to manage sample collection data and to guide testing processes. This process is fully integrated with the chain of custody and storage location.

At iMed Laboratories, we understand that accurate and reliable turnaround times on drug tests help drive your timely business decisions. We analyze samples and issue test reports within 24 hours of samples being received, provided that all specimen collection, identification, packaging and delivery requirements are followed. Results are reported in nanograms per milliliter and evaluated against cut-off levels that have been established by SAMHSA (U.S. Substance Abuse and Mental Health Services Administration).

If you don’t already have a drug-testing program in place, we can help you design and implement one. iMed’s leg al department advises its corporate clients on policy development. We provide all the necessary screening supplies, and we have built a first-class laboratory to confirm preliminary positive results.

Our Facility?

Our laboratories are designed to facilitate excellent performance for all aspects of testing.

Environmental conditions are strictly controlled and continuously monitored using reliable CFR-compliant automated electronic systems. We have rigorous security measures in place. Our facility is monitored with an intrusion alarm and CCTV cameras. Entry to the laboratory areas is strictly controlled using a fingerprint access control locking system.

We use only the finest scientific equipment, including drug test analyzers made by world-renowned manufacturers Siemens and Sciex. All testing equipment complies with the relevant specifications and is capable of achieving the accuracy required. A calibration, checking and maintenance program has been established for each piece of equipment. It is calibrated using only SANAS ISO/IEC 17025 accredited calibration laboratories as our service providers, and checked as required before being put into use.

What do we test for?

Amphetamine BDB, Butylone 2C-B, 2C-I, Cathinone MBDB MDA MDEA MDMA MDPV,Mephedrone Methamphetamine Methaqualone Methylone Methylphenidate PMA, Ritalinic AcidAmphetamine BDB, Butylone 2C-B, 2C-I, Cathinone MBDB MDA MDEA MDMA MDPV, Mephedrone Methamphetamine Methaqualone Methylone Methylphenidate PMA, Ritalinic Acid
Alprazolam, 7-Aminoclonazepam 7-Aminoflunitrazepam 7-Aminonitrazepam Bromazepam Brotizolam Chlordiazepoxide Clobazam Clonazepam Demoxepam Desalkylflurazepam, Desmethylflunitrazepam Diazepam, Estazolam Flunitrazepam Flurazepam Lorazepam,Lormetazepam Medazepam Midazolam Nitrazepam Norclobazam Nordiazepam, α-OH-Alprazolam 3-OH-Bromazepam α-OH-Midazolam, α-OH-Triazolam Oxazepam Prazepam Temazepam Triazolam
Gabapentin Pregabalin Promethazine Quetiapine
Benzoylecgonine Cocaethylene Cocaine Norcocaine
Acetylcodeine Buprenorphine Codeine Dihydrocodeine EDDP, Fentanyl Hydrocodone Hydromorphone Meconin Meperidine Methadone, 6-Monoacetylmorphine Morphine, Naloxone Naltrexone Norbuprenorphine Norcodeine Norfentanyl Normeperidine Nortapentadol Nortilidine, O-Desmethyltramadol Oxycodone Oxymorphone Papaverine Propoxyphene Sufentanil, Tapentadol Thebaine Tilidine Tramadol
Allobarbital Amobarbital Barbital Butalbital Hexobarbital Pentobarbital Phenobarbital Secbutabarbital Secobarbital Thiopental
Zaleplon Zolpidem Zopiclone


With the Corona Virus Pandemic currently affecting the World and specifically South Africa and iMed laboratories’ testing focus towards protecting the health and safety of South Africa’s, iMed recently extended their laboratory services to include Covid-19 diagnostic testing.  With no time to spare, iMed established the required infrastructure in a record time to perform molecular based diagnostic testing for Covid-19.  

Our facilities are designed to control contamination making use of mechanical barriers and spatial separation with 3 separate rooms for specimen preparation, reagent preparation and product detection, each with separate sets of equipment and supplies. Our sample preparation room is also designed to provide maximum biosafety through HEPA filtered airflow with negative air pressure. Our Laboratory design is supported by laboratory practices and controls to ensure contamination control and monitoring.

The COVID-19 RT-PCR test is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens such as nasopharyngeal swabs. Our PCR target three different viral genomic regions, reducing the risk of false negatives.

Our Laboratories are sufficiently equipped with a workflow and methodology, supported by a Laboratory Information System (LIMS), to facilitate maximum sample through-put within a minimum turnaround time. Our LIMS is set-up to allow for automated data capturing and reporting, limiting inaccurate reporting, normally the result of incorrect manual data capturing.

Corporate Responsibility

Having an addicted employee population has wide-ranging ramifications on companies and their staff. Excessive sick days, theft of inventory, reduced productivity, and diminished profits are all consequences of employee drug use. If drug abuse can be detected and the affected employees assisted with rehabilitation and recovery, vast benefits will be realized by companies and their employees.

Shipping logistics

Samples are transported using iMed’s custom-designed BioBox, a container specifically designed by our team to safely ship biological samples, such as urine. Test results are delivered digitally to our corporate clients within 24 hours of the BioBox being picked up for shipment to our facility.

High Stakes

Companies who perform drug testing must be confident the results are 100% accurate, both for their bottom lines and for the sake of their employees. Inaccurate drug testing destroys lives. Fallout can include termination of employment, lost custody of children, and potential destruction of the family unit.

Social impact

Statistics indicate that approximately 15 percent of South Africans have serious issues with drug and alcohol abuse. Not surprisingly, those numbers are mirrored in the workplace. Although companies tend to drug test their employees in pursuit of greater profits, the data gleaned from these tests can have a significant social impact when the statistics are considered as a whole. Drug addiction causes crime, poverty, and the erosion of healthy societies. It robs addicts of every important relationship they have and takes away their ability to earn a livelihood to support themselves and their families. Societies freed from rampant drug addiction have stronger infrastructures, healthier people, and thriving high-functioning economies.

Addiction is a chronic disease of the brain that often results in relapses, progressive development, and the potential for illness and death. The first point of care is detection. To fix this pervasive problem, we need the data to know where it exists. iMed’s ultimate goal is to spur social change in South Africa by using science to improve early detection of drug abuse problems.

Get In Touch

1 + 4 =

T: 0860 017 474